PharmExec Blog
Follow Us
RSS
Bookstore
Monthly Archives: November 2010
Compliance and Disclosure Risks on Anti-Competitive Promotional Spend: Is EuroLand Set to Follow the US?
New Cegedim survey documents whether European industry is ready for the challenge.
Making sense of the promotional spend and anti-corruption compliance burden is emerging as a key strategic issue for pharma — not just in the US but in the global market space as well, where regulatory safeguards are still porous. New survey research just published [...]
Posted in Global, Legal, Regulatory, compliance Tagged anti-corruption, compliance, EU, Europe, Regulatory, spend 1 Comment
A Closer Look at ProPublica
An investigative journalism organization recently took an in-depth look at pharma with its ”Dollars for Docs” report. In return, PharmExec takes a close look back at ProPublica.
Last month, PharmExec’s senior editor Walter Armstrong blogged about news organization ProPublica’s “Dollars for Docs” report, in which ProPublica—along with other news sources including National Public Radio, the PBS [...]
GE Capital CFO Survey Reveals State of Pharma Industry in 2010, 2011
Industry CFOs are driving much of the current strategy of big pharma, which is to push costs of administration and selling down to compensate for low rates of organic growth through new product introductions. This survey of their views is timely and important in gauging the direction of pharma strategy in the next year.
Last week, GE [...]
Merck Gets to the Heart of the Matter
Merck may have succeeded in making a molecule that increases “good cholesterol,” which is likely the only real breakthrough left in the anti-cholesterol and hypertension market.
It has long been known that elevated LDL cholesterol and reduced HDL cholesterol are major risk factors for developing cardiovascular disease. And while much ado has been made about a [...]
Commercial Use of Physician Information Law Overturned